Biz Groups Urge 4th Circ. To End Allergan Overcharge Suit
By Tom Lotshaw · April 6, 2026, 7:43 PM EDT
Major pharmaceutical and business associations urged the Fourth Circuit to reconsider a panel decision that revived a whistleblower lawsuit accusing an Allergan Sales LLC predecessor of overcharging Medicaid, warning it threatens...
To view the full article, register now.